Thyrocare Board to Decide FY26 Results, Dividend on May 7

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Thyrocare Board to Decide FY26 Results, Dividend on May 7
Overview

Thyrocare Technologies Limited will hold a Board meeting on May 7, 2026, to approve audited financial results for the fiscal year ended March 31, 2026. The Board will also consider recommending a final dividend for FY 2025-26. The trading window for company shares, closed since April 1, 2026, is set to reopen 48 hours after the results are announced.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Thyrocare Technologies Limited has scheduled a Board meeting for May 7, 2026, where directors will review and approve the company's audited financial results for the fiscal year ending March 31, 2026. Investors will be watching for the final figures that detail Thyrocare's performance and profitability over the past year.

The meeting agenda also includes consideration of a final dividend recommendation for the 2025-26 fiscal year. This decision offers insight into the company's cash generation and its approach to returning value to shareholders.

The company confirmed that its trading window for securities, which has been closed since April 1, 2026, will reopen 48 hours after the financial results and dividend decision are officially announced.

Following the meeting, stakeholders will focus on the specific audited financial figures, the proposed dividend amount, and any forward-looking guidance provided by management.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.